Single-molecule analysis reveals that IPMK enhances the DNA-binding activity of the transcription factor SRF
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkae1281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Hyoungjoon Ahn und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of …. Hauptthemen laut MEDLINE: Serum Response Factor, DNA, Chromatin, Phosphotransferases (Alcohol Group Acceptor). Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Samsung Foundation of Science & Technology, Suh Kyungbae Foundation.
Abstract (Originalsprache)
Serum response factor (SRF) is a master transcription factor that regulates immediate early genes and cytoskeletal remodeling genes. Despite its importance, the mechanisms through which SRF stably associates with its cognate promoter remain unknown. Our biochemical and protein-induced fluorescence enhancement analyses showed that the binding of SRF to serum response element was significantly increased by inositol polyphosphate multikinase (IPMK), an SRF cofactor. Moreover, real-time tracking of SRF loci in live cell nuclei demonstrated that the chromatin residence time of SRF was reduced by IPMK depletion in fibroblasts. Conversely, elevated IPMK levels extended the SRF–chromatin association. We identified that IPMK binds to the intrinsically disordered region of SRF, which is required for the IPMK-induced stable interaction of SRF with DNA. IPMK-mediated conformational changes in SRF were observed by single-molecule fluorescence resonance energy transfer assays. Therefore, our findings demonstrate that IPMK is a critical factor for promoting high-affinity SRF–chromatin association and provide insights into the mechanisms of SRF-dependent transcription control via chaperone-like activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea.
- College of Pharmacy, Korea University, 2511 Sejong-ro, Sejong 30019, Republic of Korea.
- Department of Biochemistry, University of Colorado, 3415 Colorado Avenue, Boulder 80303, USA.
- KAIST Institute for the BioCentury, KAIST, 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea.
- KAIST Stem Cell Center, KAIST, 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea.
ORCID-Profile: Jeongmin Yu, Kwangmin Ryu, Inkyung Jung, Ji-Joon Song, Seyun Kim
Förderung
- National Research Foundation of Korea
- Samsung Foundation of Science & Technology
- Suh Kyungbae Foundation
Zitieren
APA
Ahn, H., Yu, J., Ryu, K., Ryu, J., Kim, S., Park, J. Y., Kim, J. K., Jung, I., An, H., Hong, S., Kim, E., Park, K., Ahn, M., Min, S., Jung, I., Lee, D., Lee, T., Byun, Y., Song, J. J., …, & Kim, S. (2025). Single-molecule analysis reveals that IPMK enhances the DNA-binding activity of the transcription factor SRF. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae1281
Vancouver
Ahn H, Yu J, Ryu K, Ryu J, Kim S, Park JY, et al. Single-molecule analysis reveals that IPMK enhances the DNA-binding activity of the transcription factor SRF. Nucleic Acids Research. 2025. doi:10.1093/nar/gkae1281
BibTeX
@article{Ahn2025,
author = {Ahn, Hyoungjoon and Yu, Jeongmin and Ryu, Kwangmin and Ryu, Jaeseung and Kim, Sera and Park, Jae Yeong and Kim, Ji Kwang and Jung, Inhong and An, Haejin and Hong, Sehoon and Kim, Eunha and Park, Kihyun and Ahn, Myunghwan and Min, Sunwoo and Jung, Inkyung and Lee, Daeyoup and Lee, Thomas and Byun, Youngjoo and Song, Ji-Joon and Kim, Jaehoon and Cho, Won-Ki and Lee, Gwangrog and Kim, Seyun},
title = {Single-molecule analysis reveals that IPMK enhances the DNA-binding activity of the transcription factor SRF},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkae1281}
}
EUVIMED